150 related articles for article (PubMed ID: 35137002)
1. Implementation of the OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Scoring System in a randomized phase IIb study of abatacept in psoriatic arthritis.
Østergaard M; Bird P; Pachai C; Du S; Wu C; Landis J; Fuerst T; Ahmad HA; Connolly SE; Conaghan PG
Rheumatology (Oxford); 2022 Nov; 61(11):4305-4313. PubMed ID: 35137002
[TBL] [Abstract][Full Text] [Related]
2. Validation of the OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Score (PsAMRIS) for the Hand and Foot in a Randomized Placebo-controlled Trial.
Glinatsi D; Bird P; Gandjbakhch F; Mease PJ; Bøyesen P; Peterfy CG; Conaghan PG; Østergaard M
J Rheumatol; 2015 Dec; 42(12):2473-9. PubMed ID: 26523032
[TBL] [Abstract][Full Text] [Related]
3. The OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Score (PsAMRIS) is reliable and sensitive to change: results from an OMERACT workshop.
Bøyesen P; McQueen FM; Gandjbakhch F; Lillegraven S; Coates L; Wiell C; Haavardsholm EA; Conaghan PG; Peterfy CG; Bird P; Ostergaard M
J Rheumatol; 2011 Sep; 38(9):2034-8. PubMed ID: 21885513
[TBL] [Abstract][Full Text] [Related]
4. Testing an OMERACT MRI scoring system for peripheral psoriatic arthritis in cross-sectional and longitudinal settings.
McQueen F; Lassere M; Duer-Jensen A; Wiell C; Conaghan PG; Gandjbakhch F; Hermann KG; Bird P; Bøyesen P; Peterfy C; Ejbjerg B; Haavardsholm EA; Coates L; Ostergaard M
J Rheumatol; 2009 Aug; 36(8):1811-5. PubMed ID: 19671818
[TBL] [Abstract][Full Text] [Related]
5. Feasibility and reproducibility of the PsAMRIS-H score for psoriatic arthritis in low-field-strength dedicated extremity magnetic resonance imaging.
Strube H; Becker-Gaab C; Saam T; Reiser M; Schewe S; Schulze-Koops H; Treitl M
Scand J Rheumatol; 2013; 42(5):379-82. PubMed ID: 23713482
[TBL] [Abstract][Full Text] [Related]
6. Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritis.
Szentpetery A; Heffernan E; Gogarty M; Mellerick L; McCormack J; Haroon M; Elmamoun M; Gallagher P; Kelly G; Fabre A; Kirby B; FitzGerald O
Arthritis Res Ther; 2017 Jul; 19(1):158. PubMed ID: 28679449
[TBL] [Abstract][Full Text] [Related]
7. The OMERACT MRI in Arthritis Working Group - Update on Status and Future Research Priorities.
Østergaard M; Bird P; Gandjbakhch F; Eshed I; Haugen IK; Haavardsholm EA; Lillegraven S; Foltz V; Glinatsi D; Peterfy C; Ejbjerg B; Bøyesen P; Mease PJ; Hermann KG; Emery P; Genant HK; Conaghan PG
J Rheumatol; 2015 Dec; 42(12):2470-2. PubMed ID: 25684771
[TBL] [Abstract][Full Text] [Related]
8. Differentiating rheumatoid and psoriatic arthritis: a systematic analysis of high-resolution magnetic resonance imaging features-preliminary findings.
Abrar DB; Schleich C; Brinks R; Goertz C; Schneider M; Nebelung S; Sewerin P
Skeletal Radiol; 2021 Mar; 50(3):531-541. PubMed ID: 32845377
[TBL] [Abstract][Full Text] [Related]
9. Subclinical joint inflammation in patients with psoriasis without concomitant psoriatic arthritis: a cross-sectional and longitudinal analysis.
Faustini F; Simon D; Oliveira I; Kleyer A; Haschka J; Englbrecht M; Cavalcante AR; Kraus S; Tabosa TP; Figueiredo C; Hueber AJ; Kocijan R; Cavallaro A; Schett G; Sticherling M; Rech J
Ann Rheum Dis; 2016 Dec; 75(12):2068-2074. PubMed ID: 26916344
[TBL] [Abstract][Full Text] [Related]
10. High-resolution MRI of flexor tendon pulleys using a 16-channel hand coil: disease detection and differentiation of psoriatic and rheumatoid arthritis.
Abrar DB; Schleich C; Nebelung S; Frenken M; Radke KL; Vordenbäumen S; Brinks R; Schneider M; Ostendorf B; McGonagle D; Sewerin P
Arthritis Res Ther; 2020 Mar; 22(1):40. PubMed ID: 32122392
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Magnetic Resonance Imaging Responsiveness in Active Psoriatic Arthritis at Multiple Timepoints during the First 12 Weeks of Antitumor Necrosis Factor Therapy.
Feletar M; Hall S; Bird P
J Rheumatol; 2016 Jan; 43(1):75-80. PubMed ID: 26472408
[TBL] [Abstract][Full Text] [Related]
12. Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trial.
Conaghan PG; Durez P; Alten RE; Burmester GR; Tak PP; Klareskog L; Catrina AI; DiCarlo J; Gaillez C; Le Bars M; Zhou X; Peterfy C
Ann Rheum Dis; 2013 Aug; 72(8):1287-94. PubMed ID: 22915624
[TBL] [Abstract][Full Text] [Related]
13. Abatacept in the treatment of patients with psoriatic arthritis: results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial.
Mease P; Genovese MC; Gladstein G; Kivitz AJ; Ritchlin C; Tak PP; Wollenhaupt J; Bahary O; Becker JC; Kelly S; Sigal L; Teng J; Gladman D
Arthritis Rheum; 2011 Apr; 63(4):939-48. PubMed ID: 21128258
[TBL] [Abstract][Full Text] [Related]
14. No overall damage progression despite persistent inflammation in adalimumab-treated psoriatic arthritis patients: results from an investigator-initiated 48-week comparative magnetic resonance imaging, computed tomography and radiography trial.
Poggenborg RP; Wiell C; Bøyesen P; Boonen A; Bird P; Pedersen SJ; Sørensen IJ; Madsen OR; Slot O; Møller JM; Hasselquist M; Kubassova O; Østergaard M
Rheumatology (Oxford); 2014 Apr; 53(4):746-56. PubMed ID: 24369412
[TBL] [Abstract][Full Text] [Related]
15. Proteoglycan loss in the articular cartilage is associated with severity of joint inflammation in psoriatic arthritis-a compositional magnetic resonance imaging study.
Abrar DB; Schleich C; Nebelung S; Frenken M; Ullrich T; Radke KL; Antoch G; Vordenbäumen S; Brinks R; Schneider M; Ostendorf B; Sewerin P
Arthritis Res Ther; 2020 May; 22(1):124. PubMed ID: 32471515
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging in the assessment of metacarpophalangeal joint disease in early psoriatic and rheumatoid arthritis.
Marzo-Ortega H; Tanner SF; Rhodes LA; Tan AL; Conaghan PG; Hensor EM; Radjenovic A; O'Connor P; Emery P; McGonagle D
Scand J Rheumatol; 2009; 38(2):79-83. PubMed ID: 19177263
[TBL] [Abstract][Full Text] [Related]
17. Adalimumab markedly improves enthesitis in patients with psoriatic arthritis: Evaluation with a magnetic resonance imaging scoring system.
Yanaba K; Sadaoka A; Yonenaga T; Saeki H; Umezawa Y; Tojo S; Ito T; Kikuchi S; Fukuda K; Nakagawa H
J Dermatol; 2015 Dec; 42(12):1153-9. PubMed ID: 26109492
[TBL] [Abstract][Full Text] [Related]
18. Frequency of Arthritis-Like MRI Findings in the Forefeet of Healthy Volunteers Versus Patients With Symptomatic Rheumatoid Arthritis or Psoriatic Arthritis.
Zubler V; Agten CA; Pfirrmann CW; Weiss BG; Dietrich TJ
AJR Am J Roentgenol; 2017 Feb; 208(2):W45-W53. PubMed ID: 27929683
[TBL] [Abstract][Full Text] [Related]
19. A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial.
Axelsen MB; Eshed I; Hørslev-Petersen K; Stengaard-Pedersen K; Hetland ML; Møller J; Junker P; Pødenphant J; Schlemmer A; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Dam MY; Hansen I; Horn HC; Ammitzbøll CG; Jørgensen A; Krintel SB; Raun J; Krogh NS; Johansen JS; Østergaard M;
Ann Rheum Dis; 2015 May; 74(5):867-75. PubMed ID: 24412895
[TBL] [Abstract][Full Text] [Related]
20. Comparing Psoriatic Arthritis Low-field Magnetic Resonance Imaging, Ultrasound, and Clinical Outcomes: Data from the TICOPA Trial.
Helliwell PS; Coates LC; Chew NS; Lettieri G; Moverley AR; Freeston JE; Nam J; Waxman R; Emery P; Conaghan PG
J Rheumatol; 2020 Sep; 47(9):1338-1343. PubMed ID: 31676693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
